drugset / Trial / NCT02297139
Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
NaSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to continue to provide dasatinib to patients that are currently participating in another dasatinib trial that is ending and for which there is no other option to provide dasatinib.
Timeline
- Start
- 2015-07-31
- Primary completion
- 2022-05-15
- Completion
- 2022-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | dasatinib anhydrous | Small molecule | — | — |